Oral administration of 6-methylsulfinylhexyl isothiocyanate extracted from wasabi is safe and improves the fatigue and sleep of healthy volunteers
Tóm tắt
This study aimed to conduct a preliminary evaluation of the effects of 6-methylsulfinylhexyl isothiocyanate (6-MSITC) contained in wasabi rhizomes on fatigue and sleep and to examine its safety through overdose study. A total of 20 healthy volunteers who were experiencing daily fatigue were given powder containing 6-MSITC (4.8 mg/day of 6-MSITC) extracted from wasabi for 4 weeks. Then, fatigue, sleep, autonomic nervous functioning, stress, and immunity were evaluated. In addition, an overdose safety study of the extract powder (up to 16 mg/day of 6-MSITC for 4 weeks) was performed with 30 healthy volunteers in a double-blind, placebo-controlled method. The powder containing 6-MSITC did not improve fatigue after a mental task, but fatigue before the mental task, sleep, and mood were improved significantly after 4 weeks intake. No changes were observed in the autonomic nerve function, stress, or immune markers. In the overdose safety study, no changes in the parameters or side effects were observed, and the results showed that high doses of the extract powder containing 6-MSITC is safe. This study confirmed the possibility that this powder extracted from wasabi that contains 6-MSITC might improve fatigue and sleep. However, because the effectiveness evaluation in this study was a single-arm, open-label study and there was no placebo control group, these points must be considered when interpreting the results. Safety was confirmed in an overdose study of more than three times the amount compared to that in the efficacy evaluation study. In the future, further research should be conducted on its effectiveness for treating fatigue and sleep problems. UMIN clinical trial registration system, UMIN000049913. Registered 27 December 2022 Retrospectively registered,
https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000056818
Tài liệu tham khảo
Murata M, Uno M, Nagai Y, Nakagawa K, Okunishi I. Content of 6-Methylsulfinylhexyl isothiocyanate in Wasabi and processed Wasabi products. Nippon Shokuhin Kagaku Kogaku Kaishi. 2004;51(9):477–82.
Mizuno K, Kume T, Muto C, Takada-Takatori Y, Izumi Y, Sugimoto H, Akaike A. Glutathione biosynthesis via activation of the nuclear factor E2-related factor 2 (Nrf2) - antioxidant - response element (ARE) pathway is essential for neuroprotective effects of sulforaphane and 6-(Methylsulfinyl)hexyl isothiocyanate. J Pharmacol Sci. 2011;115:320–8.
Uto T, Hou DX, Morinaga O, Shoyama Y. Molecular mechanisms underlying anti-inflammatory actions of 6-(Methylsulfinyl)hexyl isothiocyanate derived from Wasabi (Wasabi japonica). Adv Pharmacol Sci. 2012;61:4046.
Kuno T, Hirose Y, Yamada Y, Imaida K, Takematsu K, Mori Y, Mori H. Chemoprevention of 1,2-dimethylhydrazin-induced colonic preneoplastic lesions in Fischer rats by 6-methylsulfinylhexyl isothiocyanate, a wasabi derivative. Oncol Lette. 2020;1(2):273–8.
Fuke Y, Hishinuma M, Namikawa M, Oishi Y, Matsuzaki T. Wasabi-derived 6-(methylsulfinyl)hexyl isothiocyanate induces apoptosis in human breast cancer by possible involvement of the NF-□B pathways, Nutr. Cancer. 2014;66(5):879–87.
Yano S, Wu S, Sakao K, Hou DX. Wasabi 6-(methylsulfinyl)hexyl isothiocyanate induces apoptosis in human colorectal cancer cells through p53-independent mitochondrial dysfunction pathway. BioFactors. 2018;14. https://doi.org/10.1002/biof.1431
Morimitsu Y, Hayashi K, Nakagawa Y, Horio F, Uchida K, Osawa T. Antiplatelet and anticancer isothiocyanates in japanese domestic horseradish, wasabi. BioFactors. 2000;13(1–4):271–6.
Hou DX, Fukuda M, Fujii M. and, Fuke Y. Transcriptional regulation of nicotinamide adenine dinucleotide phosphate: quinone oxidoreductase in murine hepatoma cells by 6-(methylsulfinyl)hexyl isothiocyanate, an active principle of wasabi (Eutrema wasabi maxim). Cancer Lett. 2000;161(2):195–200.
Fukuchi Y, Kato Y, Okunishi I, Matsutani Y, Osawa T, Naito M. 6-Methylsulfinylhexyl isothiocyanate, in antioxidant derived from Wasabia japonica MATUM, ameliorates diabetic nephropathy in type 2 diabetic mice. Food Sci Technol Res. 2004;10(3):290–5.
Yamada-Kato T, Nagai M, Ohnishi M, Yoshida K. Inhibitory effects of wasabi isothiocyanates on chemical mediator release in RBL-2H3 rat basophilic leukemia cells. J Nutr Sci Vitaminol (Tokyo). 2012;58(4):303–7.
Uruno A, Matsumaru D, Ryoke R, Saito R, Kadoguchi S, Saigusa D, Saito T, Saido TC, Kawashima R, Yamamoto M. Nrf2 suppresses oxidative stress and inflammation in app knock-in Alzheimer’s disease model mice. Mol Cell Biol. 2020;40(6):e00467–19. https://doi.org/10.1128/MCB.00467-19
Nakajima R. Oxidative stress suppression by ingestion of wasabi extract powder containing 6-MSITC, Japanese Society of fatigue science 18th conference (in Japanese), 2022; https://www2.aeplan.co.jp/jsfs2022/index.html
Okunishi I, Yamada-Kato T, Saito J. The effects of wasabi root extract rich in 6-(methylsulfinyl)hexyl isothiocyanate on neurocognitive functions in cognitively intact middle-aged and older adults: a randomized, double-blind, placebo-controlled trial. Jpn Pharmacol Ther. 2019;47:275–86.
Oka T, Yamada Y, Lkhagvasuren B, Nakao M, Nakajima R, Kanou M, Hiramatsu R, Nabeshima Y. (2022) Clinical effects of wasabi extract containing 6-MSITC on myalgic encephalomyelitis/chronic fatigue syndrome: an open-label trial, Biopsychosoc. Med., 2022; 16(1):26; https://doi.org/10.1186/s13030-022-00255-0
Hou DX, Korenori Y, Tanigawa S, Yamada-Kato T, Nagai M, He X, He J. Dynamics of Nrf2 and Keap1 in ARE-mediated NQO1 expression by wasabi 6-(methylsulfinyl)hexyl isothiocyanate. J Agric Food Chem. 2011;59(22):11975–82.
Watanabe Y, Kuratsune H, Kajimoto O. The handbook of Operator fatigue. Ashgate Publishing Limited; Farnham, UK: 2012. Biochemical indices of fatigue for anti-fatigue strategies and products; 209–24.
Fukuda S, Nojima J, Motoki Y, Yamaguti K, Nakatomi Y, Okawa N, Fujiwara K, Watanabe Y, Kuratsune H. A potential biomarker for fatigue: oxidative stress and anti-oxidative activity. Biol Psychol. Jul; 2016;118:88–93.
Zielinski MR, Systrom DM, Rose NR. Fatigue, sleep, and autoimmune and related disorders. Front Immunol. 2019;10:1827.
Tanaka M, Tajima S, Mizuno K, Ishii A, Konishi Y, Miike T, Watanabe Y. Frontier studies on fatigue, autonomic nerve dysfunction, and sleep-rhythm disorder. J Physiol Sci. 2015;65(6):483–98.
Laethem MV, Beckers DGJ, Dijksterhuis A, Geurts SAE. Stress, fatigue, and sleep quality leading up to and following a stressfull life event. Stress Health. 2017;33(4):459–69.
Ataka S, Tanaka M, Nozoki S, Mizuma H, Mizuno K, Tahata T, Sugino T, Shirai T, Kajimoto Y, Kutatsune H, Kajimoto O, Watanabe Y. Effects of oral administration of caffeine and D-ribose on mental fatigue. Nutrition. 2008;24(3):233–8.
Ernster L, Forsmark-Andree P. Ubiquinol: an endogenous antioxidant in aerobic organisms. Clin Investig. 1993;71(8 Supple):60–S65.
Judy WV, Stogsdill WW, And Folkers K. Myocardial preservation by therapy with coenzyme Q10 during heart surgery. Clin Investig. 1993;71(8 Suppl):155–S161.
Takumi H, Fujishima N, Shiraishi K, Mori Y, Ariyama A, Kometani T, Hashimoto S, Nadamoto T. Effects of alpha-glucosylhesperidin on the peripheral body temperature and autonomic nervous systems. Biosci Biotechnol Biochem. 2010;74(4):707–15.
Kimura R, Murata T. Influence of alkylamides of glutamic acid related compounds on the central nervous system. I. Central depressant effect of Theanine. Chem Pharm Bull (Tokyo). 1971;19(6):1257–61.
Imai J, Ide N, Nagae S, Moriguchi T, Matsuura H, Itakura Y. Antioxidant and radical scavenging effects of aged garlic extract and its constituents. Planta Med. 1994;60(5):417–20.
Wang L, Mimura K, Fujimoto S. Effect of black garlic supplementation on exercise-induced physiological responses. J Phys Fitness Sports Med. 2012;1(4):685–94.
Matsui K, Kita K, Nagata Y, Hashiguchi K, Yamazaki K, Takashige Y, Yamashita S, Saito M. A study on the mechanism of sleep quality improvement and fatigue reduction by ingestion of food containing fermented garlic extract―A randomized, double-blind, placebo-controlled, parallel-group trial. J Pharma Ther. 2022;50:673–86. (in Japanese).
Okunishi I, Yamada-Kato T, Saito J, Hou D. Safety evaluation of 6-(methylsulfinyl) hexyl isothiocyanate (6-MSITC) and wasabi sulfinyl, a 6-MSITC-containing supplement. Food Sci Technol Res. 2020;26(6):813–24.